References
- H. W. Hui, J. R. Robinson and V. H. L. Lee, Design and Fabrication of Oral Controlled Release Drug Delivery Systems, in Controlled Drug Delivery: Fundamentals and Applications (Eds. J. R. Robinson and V. H. L. Lee), 2nd ed., Marcel Dekker, New York 1987, pp. 373-374.10.1201/b14193-12
- R. K. Verma, B. Mishra and S. Garg, Osmotically controlled oral drug delivery, Drug Dev. Ind. Pharm. 26 (2000) 695-708; DOI: 10.1081/DDC-100101287.10.1081/DDC-100101287
- M. Speers and C. Bonnano, Economic Aspects of Controlled Drug Delivery, in Encyclopedia of Controlled Drug Delivery (Ed. E. Mathiowitz), Wiley, New York 1999, pp. 341-347.
- R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Control. Rel. 79 (2002) 7-27; DOI: 10.1016/j.conrel.2003.09.009.
- F. Theeuwes, Elementary osmotic pump, J. Pharm. Sci. 64 (1975) 1987-1991; DOI: 10.1002/jps. 2600641218.
- P. Kumar, S. Singh, P. S. Rajinikanth and B. Mishra, An overview of osmotic pressure controlled release formulation, J. Pharm. Res. 5 (2006) 34-45.
- P. Kumar and B. Mishra, An overview of recent patents on oral osmotic drug delivery systems, Recent Patents on Drug. Del. Form. 1 (2007) 236-255; DOI: 10.2174/187221107782331638.10.2174/187221107782331638
- S. A. Schug, Tramadol in acute pain, Acute Pain 5 (2003) 1-3; DOI: 10.1016/S1366-0071(03) 00028-7.
- C. Mattia and F. Coluzzi, Once-daily tramadol in rheumatological pain, Expert. Opin. Pharmacother. 7 (2006) 1811-1815; DOI: 10.1517/14656566.7.13.1811.10.1517/14656566.7.13.1811
- S. B. Tiwari, K. Murthy, M. R. Pai, P. R. Mehta and P. S. Choudhary, Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system, AAPPS Pharm. Sci. Tech. 4 (2003) 1-6.
- P. Kumar, S. Singh and B. Mishra, Gastroretentive drug delivery system of ranitidine hydrochloride based on osmotic technology: development and evaluation, Curr. Drug Del. 5 (2008) 332-342; DOI: 10.2174/156720108785914943.10.2174/156720108785914943
- J. Shokri, P. Ahmedi, P. Rashidi, M. Shahsavri, A. R. Siahboomi and A. Nokhodchi, Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water soluble drugs, Eur. J. Pharm. Biopharm. 68 (2008) 289-297; DOI: 10.1016/j.ejpb.200706.006.
- United States Pharmacopoeia 30, National Formulary vol. 1, USP Convention, Rockville 2007.
- C. Aguzzi, M. C. Bonferoni, M. R. Osorio, F. S. Rossi, F. Ferrari and C. Caramella, Influence of complex solubility on formulations based on lambda carrageenan and basic drugs, AAPPS Pharm. Sci. Tech. 3 (2002) 1-7.
- M. R. Rouini, Y. H. Ardakani, F. Soltani, H. Y. Aboul-Enein and A. Foroumadi, Development and validation of rapid HPLC method for simultaneous determination of tramadol and its metabolites in human plasma, J. Chromatogr. B. 830 (2006) 207-211; DOI: 10.1016/j.jchromb.2005.10.039.10.1016/j.jchromb.2005.10.039
- A. Kucuk, Y. Kadioglu and F. Celebi, Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction, J. Chrom. B. 816 (2005) 203-208; DOI: 10.1016/j.jchromb. 2004.11.031.
- P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1
- B. Mishra, B. V. Bakde, P. N. Singh and P. Kumar, Development and in-vitro evaluation of oral sustained release formulation of tramadol hydrochloride, Acta Pharm. Sci. 48 (2006) 153-166.
- X. Li, W. Pan, S. Nie and L. Wu, Studies on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe, J. Control. Rel. 96 (2004) 359-367; DOI: 10.1016/j/jconrel.2004.01.026.
- N. Sinchaipanid, S. Pongwai, P. Limsuwan and A. Mitrevej, Design of salbutamol EOP tablets from pharmacokinetic parameters, Pharm. Dev. Technol. 8 (2003) 135-142; DOI: 10.1081/PDT-120018479.10.1081/PDT-120018479
- F. Musshoff and B. Madea, Fatality due to ingestion of tramadol alone, Forensic Sci. Int. 116 (2001) 197-199; DOI: 10.1016/s0379-0738(00)00374-1.10.1016/S0379-0738(00)00374-1
- A. M. Razaghi and J. B. Schwartz, Investigation of cyclobenzaprine hydrochloride release from oral osmotic delivery systems containing a water swellable polymer, Drug Dev. Ind. Pharm. 28 (2002) 631-639; DOI: 10.1018.DDC-120003855.10.1081/DDC-120003854
- A. M. Razaghi and J. B. Schwartz, Release of cyclobenzaprine hydrochloride from osmotically rupturable tablets, Drug. Dev. Ind. Pharm. 28 (2002) 695-701; DOI: 10.1081/DDC-120003861.10.1081/DDC-120003861
- ICH Q1A (R2), Stability Testing Guidelines: Stability Testing of New Drug Substances and Products, EMEA, London 2003.